At the interface of computational and experimental drug discovery, Congruence Therapeutics is designing novel small molecules to treat diseases caused by protein misfolding.
At the interface of computational and experimental drug discovery, Congruence Therapeutics is designing novel small molecules to treat diseases caused by protein misfolding.